Clinical trial
Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications in High-risk Patients: a Randomized, Double-blind, and Placebo Controlled Study
NCT02644876 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications in High-risk Patients: a Randomized, Double-blind, and Placebo Controlled Study
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 1, 2015
- Completion date
- December 10, 2018
- Enrollment
- 864 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.